Log in to save to my catalogue

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with c...

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b9772dfe6e6c41dcb1618e30d5c691a1

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

About this item

Full title

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

Publisher

England: BioMed Central Ltd

Journal title

Molecular cancer, 2021-10, Vol.20 (1), p.134-134, Article 134

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

DEAD box helicase 3, X-linked (DDX3X) is an ATP-dependent RNA helicase and is involved in multiple cancer-related cellular processes, including transcriptional regulation, cell adhesion, signal transduction and stemness [3]. Recurrent DDX3X mutations in DLBCL are associated with worse clinical outcomes Navigation through NHL patient samples in the...

Alternative Titles

Full title

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b9772dfe6e6c41dcb1618e30d5c691a1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b9772dfe6e6c41dcb1618e30d5c691a1

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-021-01437-0

How to access this item